K. Aldape, G. Zadeh, S. Mansouri, G. Reifenberger, and A. Von-deimling, Glioblastoma: pathology, molecular mechanisms and markers, Acta Neuropathologica, vol.132, issue.Suppl 4, pp.829-877, 2015.
DOI : 10.1242/dev.02162

T. Cloughesy, W. Cavenee, and P. Mischel, Glioblastoma: From Molecular Pathology to Targeted Treatment, Annual Review of Pathology: Mechanisms of Disease, vol.9, issue.1, pp.1-25, 2014.
DOI : 10.1146/annurev-pathol-011110-130324

R. Costa, B. Carneiro, T. Taxter, F. Tavora, A. Kalyan et al., <i>FGFR3-TACC3</i> fusion in solid tumors: mini review, Oncotarget, vol.7, issue.34, pp.55924-55962, 2016.
DOI : 10.18632/oncotarget.10482

URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=10482&path%5B%5D=33118

D. Stefano, A. Fucci, A. Frattini, V. Labussiere, M. Mokhtari et al., Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma, Clinical Cancer Research, vol.21, issue.14, pp.3307-3324, 2015.
DOI : 10.1158/1078-0432.CCR-14-2199

URL : https://hal.archives-ouvertes.fr/hal-01317544

Z. Gaber, S. Butler, and B. Novitch, PLZF Regulates Fibroblast Growth Factor Responsiveness and Maintenance of Neural Progenitors, PLoS Biology, vol.450, issue.10, p.1001676, 2013.
DOI : 10.1371/journal.pbio.1001676.s010

A. Gonzalez-aguilar, A. Idbaih, B. Boisselier, N. Habbita, M. Rossetto et al., Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas, Clinical Cancer Research, vol.18, issue.19, pp.5203-5214, 2012.
DOI : 10.1158/1078-0432.CCR-12-0845

K. Granberg, M. Annala, B. Lehtinen, J. Kesseli, J. Haapasalo et al., Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas. Neuro Oncol. Epub ahead print. doi: 10. 1093/neuonc/nox028 Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis, J Clin Oncol, vol.821, issue.20, pp.3798-807, 2003.

I. Blumcke, D. Capper, M. Karajannis, R. Benayed, L. Chavez et al., Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway, Acta Neuropathol, vol.133, issue.3, pp.417-446, 2017.

T. Jue and K. Mcdonald, The challenges associated with molecular targeted therapies for glioblastoma, Journal of Neuro-Oncology, vol.344, issue.1, pp.427-461, 2016.
DOI : 10.1016/j.canlet.2013.10.010

K. Kang, S. Lee, J. Han, J. Choi, and M. Song, The complex morphology of reactive astrocytes controlled by fibroblast growth factor signaling Epithelioid GBMs show a high percentage of BRAF V600E mutation, Glia. Am J Surg Pathol, vol.6237, issue.125, pp.1328-44685, 2013.

M. Kurobe, T. Kojima, K. Nishimura, S. Kandori, T. Kawahara et al., Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes, WK (2016) WHO classification of tumours of the central nervous system, Revised. 4th update Edition, International Agency for Research On Cancer: Lyon. 16, pp.1200-1206, 2014.

A. Olshen, E. Venkatraman, R. Lucito, and M. Wigler, Circular binary segmentation for the analysis of array-based DNA copy number data, Biostatistics, vol.5, issue.4, pp.557-72, 2004.
DOI : 10.1093/biostatistics/kxh008

K. Peters, D. Ornitz, S. Werner, and L. Williams, Unique Expression Pattern of the FGF Receptor 3 Gene during Mouse Organogenesis, Developmental Biology, vol.155, issue.2, pp.423-453, 1993.
DOI : 10.1006/dbio.1993.1040

N. Pringle, W. Yu, M. Howell, J. Colvin, D. Ornitz et al., Fgfr3 expression by astrocytes and their precursors: evidence that astrocytes and oligodendrocytes originate in distinct neuroepithelial domains, Development, vol.130, issue.1, pp.93-102, 2003.
DOI : 10.1242/dev.00184

URL : http://dev.biologists.org/content/develop/130/1/93.full.pdf

D. Reuss, A. Kratz, F. Sahm, D. Capper, D. Schrimpf et al., Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities, Acta Neuropathologica, vol.226, issue.3, pp.407-424, 2015.
DOI : 10.1002/path.2995

M. Sanson and A. Idbaih, Neuro-oncology: Novel molecular targets in treatment of glioblastoma, Nature Reviews Neurology, vol.501, issue.11, pp.612-615, 2013.
DOI : 10.1038/nature12625

M. Sanson, Y. Marie, S. Paris, A. Idbaih, J. Laffaire et al., Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas, Journal of Clinical Oncology, vol.27, issue.25, pp.4150-4154, 2009.
DOI : 10.1200/JCO.2009.21.9832

D. Singh, J. Chan, P. Zoppoli, F. Niola, R. Sullivan et al., Transforming fusions of FGFR and TACC genes in human glioblastoma Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Science. Nature, vol.337, issue.60997216, pp.1231-1236, 2008.